OpenExamsFREE PRACTICE — ANY EXAM

Nevada Optometrist — Requirements & Free Practice

US-NV · License preparation

956 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

licenses to operate extended clinical facilities for the treatment of visual disorders

Institutional license for an accredited optometry school or college to operate an extended clinical facility treating visual disorders beyond its principal campus.

Licensing authority: Nevada State Board of Optometry

Initial extended clinical facility licensure
No examination is required for this applicant pathway.
Applicant
Applicant is an accredited optometry school or college establishing a facility beyond its principal campus.
Application
Submit the proposed facility name and address, desired opening date, facility and equipment description, kinds of services, and names, addresses, academic qualifications and licenses of instructors or clinicians.
Individual Licensure
NRS 636.028(2) separately requires a clinician or instructor who practices optometry in Nevada to be licensed by the Board. The institutional route does not substitute for that professional license.

Official no-examination sources

Effective from 2026-09-22.

Renewal of extended clinical facility license
No examination is required for this applicant pathway.
Changes
Notify the Board of changes in instructors or clinicians, location, or clinical-program content.
Existing License
Hold an extended-clinical-facility license.
Renewal
The license is effective until February 28 of the next even-numbered year unless renewed by the Board upon payment of the prescribed fee.

Official no-examination sources

Effective from 2026-09-22.

certificate of registration of the assumed or fictitious name

Registration allowing an actively licensed optometrist to own all or part of an optometry practice under an assumed or fictitious name at a specific location.

Licensing authority: Nevada State Board of Optometry · Application information

New registration after a change of ownership
No examination is required for this applicant pathway.
Materials
Identify every owner and percentage and provide the required local name-registration documentation and fee.
Ownership Change
Submit a new name-registration application no later than 90 calendar days after any ownership percentage changes.

Official no-examination sources

Effective from 2026-09-22.

Initial registration of an assumed or fictitious practice name
No examination is required for this applicant pathway.
Application
Submit a separate application for each location, all owners and ownership percentages, local name-registration approval and the fee.
License
Hold an active Nevada optometry license.
Name
Comply with NAC 636.215 restrictions on misleading, price, superiority or physician wording.

Official no-examination sources

Effective from 2026-09-22.

Certificate to Treat Persons Diagnosed with Glaucoma

Certificate authorizing optometrists to treat persons diagnosed with glaucoma, with an endorsement pathway and required referrals for specified patients.

Licensing authority: Nevada State Board of Optometry · Application information

Glaucoma certification by co management
Treatment and Management of Ocular Disease (TMOD)
Diagnosis
The consulting ophthalmologist must diagnose or confirm each glaucoma diagnosis.
Experience
Treat at least 15 glaucoma patients in consultation with a licensed ophthalmologist for at least 12 consecutive months each, with at least three examinations per patient and a treatment plan of at least one year.
License
Hold a Nevada optometry license in good standing.
Opac
Possess a valid Nevada OPAC certificate.
Patient Restrictions
Follow NRS 636.2891 restrictions and required referral to an ophthalmologist.
Records
Submit the Board patient documentation and sworn optometrist and ophthalmologist statements required by NAC 636.280 and 636.290.
Tmod
Successfully pass NBEO TMOD; another Board-approved equivalent is an unnamed condition, not an invented alternative leaf.
Expedited glaucoma certification by endorsement
No examination is required for this applicant pathway.
Application
Submit the prescribed application, truthful affidavit, supporting evidence and fee.
Board Implementation
Policy Number 12 and the current application ask for at least 50 glaucoma patient contacts or substantially similar qualifying requirements in the other jurisdiction.
License
Hold a Nevada optometry license in good standing.
National Practitioner Data Bank
Have no adverse actions reported in the past five years.
Opac
Hold a valid Nevada OPAC certificate. Existing certification is a condition, not an indirect repetition of its TMOD requirement.
Other Credential
Hold a valid and unrestricted glaucoma credential from an eligible US jurisdiction that the Board determines was issued on substantially similar requirements.

Official no-examination sources

Effective from 2026-09-22.

Glaucoma certification by co management after license expiration
Treatment and Management of Ocular Disease (TMOD)
Diagnosis
The consulting ophthalmologist must diagnose or confirm each glaucoma diagnosis.
Experience
Treat at least 15 glaucoma patients in consultation with a licensed ophthalmologist for at least 12 consecutive months each, with at least three examinations per patient and a treatment plan of at least one year.
Expired License
Policy Number 4 directs an expired licensee to reapply for the Nevada license and glaucoma certification if eligible, with all respective fees.
License
Hold a Nevada optometry license in good standing.
Opac
Possess a valid Nevada OPAC certificate.
Patient Restrictions
Follow NRS 636.2891 restrictions and required referral to an ophthalmologist.
Records
Submit the Board patient documentation and sworn optometrist and ophthalmologist statements required by NAC 636.280 and 636.290.
Tmod
Successfully pass NBEO TMOD; another Board-approved equivalent is an unnamed condition, not an invented alternative leaf.
Glaucoma certification by endorsement after license expiration
No examination is required for this applicant pathway.
Application
Submit the prescribed application, truthful affidavit, supporting evidence and fee.
Board Implementation
Policy Number 12 and the current application ask for at least 50 glaucoma patient contacts or substantially similar qualifying requirements in the other jurisdiction.
Expired License
Reapply for the Nevada license and glaucoma certification if eligible, paying all respective fees.
License
Hold a Nevada optometry license in good standing.
National Practitioner Data Bank
Have no adverse actions reported in the past five years.
Opac
Hold a valid Nevada OPAC certificate. Existing certification is a condition, not an indirect repetition of its TMOD requirement.
Other Credential
Hold a valid and unrestricted glaucoma credential from an eligible US jurisdiction that the Board determines was issued on substantially similar requirements.

Official no-examination sources

Effective from 2026-09-22.

Permit to Provide Optometric Services for a Health Maintenance Organization

Permit required for a Nevada-licensed optometrist to be employed by or contract with a health maintenance organization to provide services.

Licensing authority: Nevada State Board of Optometry · Application information

Permit for HMO employment or contracting
No examination is required for this applicant pathway.
Documents
Submit the employment agreement or contract and all renewals or extensions, the HMO certificate of authority, and evidence that the agreement does not require any violation of NRS or NAC Chapter 636.
License
Be a Nevada-licensed optometrist.

Official no-examination sources

Effective from 2026-09-22.

License to Practice Optometry

Ordinary Nevada optometrist license, including active and inactive status and restoration routes.

Licensing authority: Nevada State Board of Optometry · Application information

Reinstatement following a child support suspension
No examination is required for this applicant pathway.
Official Letter
The Board must receive the district attorney or other public agency letter under NRS 425.550 stating that the licensee has complied with the subpoena or warrant or satisfied the arrearage under NRS 425.560.

Official no-examination sources

Effective from 2026-09-22.

Discretionary restoration of a revoked or suspended license
No examination is required for this applicant pathway.
Board Discretion
Under NRS 636.340 the Board may restore absolutely or on specified conditions; satisfy the individual order and any conditions the Board imposes. No currently identified examination is fixed for this route.
Child Support Exception
NRS 636.340 does not apply to a license suspended pursuant to NRS 425.540.
Waiting Period
Apply on or after one year following revocation or suspension.

Official no-examination sources

Effective from 2026-09-22.

Expedited licensure by endorsement under NRS 636.206
Affidavit
Submit an affidavit that the application and accompanying material are true and correct.
Application
Submit the completed application, prescribed fees, truthful disclosures, recent passport photograph, and any requested supporting documents.
Board General National Demand
The general Board License Requirements page states: "You must obtain a passing score on all three parts of the National Board of Examiners in Optometry examination and the TMOD exam, and request that the NBEO release your scores to Nevada; A 70% score is required to pass the Nevada Online State Law Exam (OSLE), which is offered online at http://www.optometry.org/ . " NRS 636.150 and 636.155 expressly except endorsement under NRS 636.206; NRS 636.206 itself identifies prior passage of NBEO comprehensive parts, but does not identify TMOD. The endorsement-specific supporting-document list requires OSLE. The general page additional TMOD demand is retained here as an applicant-facing Board instruction.
Child Support
Submit the statement required by NRS 636.159 and comply with any applicable child-support order or approved repayment plan.
Disciplinary Record
Have not been disciplined and are not currently under investigation by any corresponding licensing authority where a license is or was held.
License Held
Hold a corresponding valid, active and unrestricted optometry license in the District of Columbia or a US state or territory.
Malpractice
Have not been held civilly or criminally liable for malpractice; NAC 636.077 includes professional negligence.
National Practitioner Data Bank
Have no adverse actions reported to the National Practitioner Data Bank in the past five years.
Practice Experience
Have been continuously and actively engaged in optometry practice for the past five years.
Practice Location
Before practicing, notify the Board of the initial Nevada practice location or locations.
Prior Licensure
Disclose every past or current optometry license and arrange verification or a current letter of good standing from each jurisdiction.
Prior National Passage
NRS 636.206 requires passage of every part of the comprehensive NBEO examination as a prerequisite to the corresponding license already held. The currently offered registered Parts I, II and III remain requirement leaves.
Prior Nevada License
Have not held a Nevada optometry license in the immediately preceding year.
State Score
The Board endorsement application and Policy Number 3 require passage of Nevada OSLE; Policy Number 3 specifies at least 70%.
Transcripts
The Board License Requirements page exempts endorsement applicants from submitting transcripts.
Initial licensure by examination
Age
Be at least 21 years of age.
Application
Submit the completed application, prescribed fees, truthful disclosures, recent passport photograph, and any requested supporting documents.
Child Support
Submit the statement required by NRS 636.159 and comply with any applicable child-support order or approved repayment plan.
Discipline
Have not been disciplined for harming a patient as an optometrist licensed in another state.
Education
Graduate from a Board-accredited or Board-approved school of optometry; arrange direct delivery of official transcripts.
National Scores
Pass each national examination identified in NAC 636.075 and arrange NBEO release of scores to Nevada. TMOD may be passed in the embedded or stand-alone administration of the same registered examination.
Practice Location
Before practicing, notify the Board of the initial Nevada practice location or locations.
Prior Licensure
Disclose every past or current optometry license and arrange verification or a current letter of good standing from each jurisdiction.
State Score
Pass Nevada OSLE with a score of at least 70%.
Reapplication following expiration of a Nevada license
Age
Be at least 21 years of age.
Application
Submit the completed application, prescribed fees, truthful disclosures, recent passport photograph, and any requested supporting documents.
Child Support
Submit the statement required by NRS 636.159 and comply with any applicable child-support order or approved repayment plan.
Discipline
Have not been disciplined for harming a patient as an optometrist licensed in another state.
Education
Graduate from a Board-accredited or Board-approved school of optometry; arrange direct delivery of official transcripts.
Expired License
Board Policy Number 4 requires an expired licensee to submit the application, documentation and fees required of a new licensee; follow the ordinary examination route, or the separately represented endorsement route if its conditions are satisfied.
National Scores
Pass each national examination identified in NAC 636.075 and arrange NBEO release of scores to Nevada. TMOD may be passed in the embedded or stand-alone administration of the same registered examination.
Practice Location
Before practicing, notify the Board of the initial Nevada practice location or locations.
Prior Licensure
Disclose every past or current optometry license and arrange verification or a current letter of good standing from each jurisdiction.
State Score
Pass Nevada OSLE with a score of at least 70%.
Expedited military related licensure by endorsement under NRS 636.207
Nevada Online State Law Exam (OSLE)
Affidavit
Submit a truthful affidavit and any other information required by the Board.
Application
Submit the completed application, prescribed fees, truthful disclosures, recent passport photograph, and any requested supporting documents.
Board General National Demand
The general Board License Requirements page states: "You must obtain a passing score on all three parts of the National Board of Examiners in Optometry examination and the TMOD exam, and request that the NBEO release your scores to Nevada; A 70% score is required to pass the Nevada Online State Law Exam (OSLE), which is offered online at http://www.optometry.org/ . " This instruction is recorded as a condition for military applicants under the statutory exception; the national exams are not imposed as leaves by NRS 636.207.
Child Support
Submit the statement required by NRS 636.159 and comply with any applicable child-support order or approved repayment plan.
Discipline
Have not been disciplined or investigated by the corresponding regulatory authority of a jurisdiction in which a license is held.
License Held
Hold a corresponding valid and unrestricted optometry license in the District of Columbia or a US state or territory.
Malpractice
Have not been held civilly or criminally liable for malpractice; NAC 636.077 includes professional negligence.
Military Status
Be an active member of the US Armed Forces, the spouse of an active member, a veteran, or the surviving spouse of a veteran.
Practice Location
Before practicing, notify the Board of the initial Nevada practice location or locations.
Prior Licensure
Disclose every past or current optometry license and arrange verification or a current letter of good standing from each jurisdiction.
State Score
Policy Number 3 requires all applicants, including applicants for endorsement, to pass Nevada OSLE with at least 70%.
Statutory Exception
NRS 636.150 and 636.155 except NRS 636.207 applicants from the ordinary examination and qualification provisions; NRS 636.207 contains no identified national-examination requirement.
Change from inactive to active status
No examination is required for this applicant pathway.
Application
Submit the status-change form, Nevada license number, primary practice location (home address if there is none), email and the activation fee.
Status
Hold an existing inactive Nevada optometry license.

Official no-examination sources

Effective from 2026-09-22.

Biennial renewal of active license
No examination is required for this applicant pathway.
Continuing Education
Complete 40 hours in the prior two years, or 50 hours for OPAC licensees with at least 30 related to pharmaceutical agents or disease; the Board may waive all or part for good cause.
Course Assessment
For asynchronous or correspondence CE, provide proof of at least 70% on the course examination. These unnamed course tests are applicant conditions, not registered professional examination leaves.
Deadline
Renew before March 1 of each even-numbered year.
Materials
Submit the prescribed renewal form, all required information, fees and evidence of continuing education.
Status
Hold an existing active Nevada license.

Official no-examination sources

Effective from 2026-09-22.

Biennial renewal of inactive license
No examination is required for this applicant pathway.
Continuing Education
Complete 40 hours in the prior two years, or 50 hours for OPAC licensees with at least 30 related to pharmaceutical agents or disease; the Board may waive all or part for good cause.
Course Assessment
For asynchronous or correspondence CE, provide proof of at least 70% on the course examination. These unnamed course tests are applicant conditions, not registered professional examination leaves.
Deadline
Renew before March 1 of each even-numbered year.
Materials
Submit the prescribed renewal form, all required information, fees and evidence of continuing education.
Status
Hold an existing inactive Nevada license.

Official no-examination sources

Effective from 2026-09-22.

Restoration following suspension for renewal noncompliance
No examination is required for this applicant pathway.
Board Timing Notice
Board Policy Number 4 instead says restoration materials may be submitted on or before June 30 and that expiration occurs July 1: "On March 1 of even-numbered years, any non-renewed licensee’s ability to practice optometry in Nevada will be suspended. A license may be relieved from suspension by submitting the required renewal materials and fees to the Board on or before June 30 and paying a penalty of $500.00 as authorized by NRS 636.285. As of July 1, the license to practice and any certificates held by a non-renewed licensee will expire. Should an expired licensee wish to practice again in Nevada, he or she must submit an application and all documentation and fees required of a new licensee. " The statutory 90-day and day-91 rules control.
Materials
Pay the renewal and late fees, submit all required information, and complete the required continuing education.
Window
Apply within 90 days after suspension under NRS 636.275; the license expires on day 91 if not restored.

Official no-examination sources

Effective from 2026-09-22.

Reinstatement when no formal complaint is pending at the summary suspension hearing
No examination is required for this applicant pathway.
Hearing
No formal complaint is pending before the Board on the hearing date; NRS 636.3395(3) then requires reinstatement.
Suspension
The license was summarily suspended under NRS 636.3395.

Official no-examination sources

Effective from 2026-09-22.

Certificate to Own or Operate a Mobile Optometry Clinic

Clinic certificate; individual optometrists providing care must hold their own professional license.

Licensing authority: Nevada State Board of Optometry · Application information

Initial mobile clinic certification for a licensed optometrist
No examination is required for this applicant pathway.
Application
Submit the prescribed application, associated physical address and required fees.
Owner
Applicant is a licensed optometrist in Nevada.
Records
Licensed optometrists maintain patient records and service-date and location records under NAC 636.275.
Services
Provide services only to the groups authorized in NRS 636.2899; services must be directed and controlled by a licensee, who conducts final patient examinations.

Official no-examination sources

Effective from 2026-09-22.

Initial mobile clinic certification for a nonprofit or charitable organization, governmental agency or school
No examination is required for this applicant pathway.
Application
Submit the prescribed application, associated physical address and required fees.
Owner
Applicant is a nonprofit or charitable organization, governmental agency or school in Nevada.
Records
Licensed optometrists maintain patient records and service-date and location records under NAC 636.275.
Services
Provide services only to the groups authorized in NRS 636.2899; services must be directed and controlled by a licensee, who conducts final patient examinations.

Official no-examination sources

Effective from 2026-09-22.

Biennial renewal of mobile clinic certification
No examination is required for this applicant pathway.
Application
Submit the prescribed renewal application and fee, maintaining the authorized ownership, service and record conditions.
Deadline
Renew on or before March 1 of each even-numbered year.
Existing Certificate
Hold an existing mobile-clinic certificate.

Official no-examination sources

Effective from 2026-09-22.

Certificate to Administer and Prescribe Pharmaceutical Agents

Certification to administer and prescribe pharmaceutical agents for Nevada-licensed optometrists in good standing.

Licensing authority: Nevada State Board of Optometry · Application information

Reapplication for pharmaceutical agent certification after license expiration
Treatment and Management of Ocular Disease (TMOD)
Controlled Substances
Controlled-substance prescribing also requires the separate applicable registration and statutory training; this certification does not by itself remove those conditions.
Declaration
Certify under penalty of perjury on the Board form that all pharmaceutical-agent certification requirements are satisfied.
Equivalent Exam
NRS 636.287 permits an equivalent examination approved by the Board; no other examination is identified in the obtained rule or current declaration.
Expired License
Reapply for the Nevada license and OPAC certification, pay the respective fees and satisfy the current certification requirements.
License
Hold a Nevada optometry license in good standing.
Prior Training
Policy Number 4 states approved OPAC training is valid for the life of the licensee and need not be repeated.
Score Verification
Have successfully passed NBEO TMOD; the Board must receive verification directly from the testing agency. Prior passage is a leaf because TMOD remains offered.
Initial pharmaceutical agent certification
Treatment and Management of Ocular Disease (TMOD)
Controlled Substances
Controlled-substance prescribing also requires the separate applicable registration and statutory training; this certification does not by itself remove those conditions.
Declaration
Certify under penalty of perjury on the Board form that all pharmaceutical-agent certification requirements are satisfied.
Equivalent Exam
NRS 636.287 permits an equivalent examination approved by the Board; no other examination is identified in the obtained rule or current declaration.
License
Hold a Nevada optometry license in good standing.
Score Verification
Have successfully passed NBEO TMOD; the Board must receive verification directly from the testing agency. Prior passage is a leaf because TMOD remains offered.

Certificate as a Substitute Optometrist

Certificate permitting an optometrist to practice as a substitute for more than 28 working days between license renewals, subject to location restrictions.

Licensing authority: Nevada State Board of Optometry · Application information

Initial issuance of substitute optometrist certificate
No examination is required for this applicant pathway.
Application
Apply on the prescribed Board form and pay the applicable fee.
License
Hold a Nevada optometry license.
Log
The current Board application asks for a written log of dates, locations and substituted optometrists submitted quarterly.
Renewal
Renew before the ordinary license renewal date.
Use
Certificate permits more than 28 total working days as a substitute during a licensing period. No more than 28 working days at any single unregistered location, except within a certified mobile clinic.

Official no-examination sources

Effective from 2026-09-22.

Biennial renewal of substitute optometrist certificate
No examination is required for this applicant pathway.
Application
Apply on the prescribed Board form and pay the applicable fee.
License
Hold a Nevada optometry license.
Log
The current Board application asks for a written log of dates, locations and substituted optometrists submitted quarterly.
Renewal
Renew before the ordinary license renewal date.
Use
Certificate permits more than 28 total working days as a substitute during a licensing period. No more than 28 working days at any single unregistered location, except within a certified mobile clinic.

Official no-examination sources

Effective from 2026-09-22.

Treatment and Management of Ocular Disease (TMOD)

Provider
National Board of Examiners in Optometry (NBEO)
Format
Image-intensive, case-based examination; each patient case is followed by 3-6 related multiple-choice items with 3-10 answer options, single-answer or multiple-response. Offered as a stand-alone examination or as an embedded portion of the Part II PAM examination, with a separate TMOD score and pass/fail decision
Exam questions
120 items administered in a single session
Exam fee
$630 for the stand-alone TMOD (rates for examinations administered beginning August 2026); no separate registration when taken embedded in Part II PAM
Examination outline
  • Clinical Correlation of Basic Science Principles
    • Clinical Correlation of Basic Science Principles — Pathophysiology/etiology
    • Clinical Correlation of Basic Science Principles — anatomy
    • Clinical Correlation of Basic Science Principles — biochemistry
    • Clinical Correlation of Basic Science Principles — physiology
    • Clinical Correlation of Basic Science Principles — immunology/microbiology/pathology
    • Clinical Correlation of Basic Science Principles — optics
    • Clinical Correlation of Basic Science Principles — pharmacology
  • Diagnosis
    • Diagnosis — Most appropriate diagnosis
    • Related to Diagnosis — Indicate data supporting or correlating with diagnosis; correlation of possible additional data; or indicate additional data or next test needed
  • Treatment / Management
    • Treatment/Management — Most appropriate treatment/management
    • Related to Treatment/Management — Treatment mechanism, additional data needed to treat effectively, additional data or next test needed, patient education, follow-up, or prognosis
Examination sources

Part I Applied Basic Science (ABS)

Provider
National Board of Examiners in Optometry (NBEO); delivered at Pearson testing centers
Format
One-day computer-based examination; most items require choosing the single best or correct answer, and approximately 10-15% are multiple-response items (2, 3, or 4 responses) scored as completely correct or incorrect with no partial credit
Exam questions
370 items: 350 scored items and 20 unscored (pre-test) items
Time limit
Two sessions of 185 items each, 4 hours per session; the first session includes an additional 15 minutes for a tutorial and non-disclosure agreement, with an optional break of up to 45 minutes between sessions
Passing score
Scaled score on a 100-900 scale; anything above 300 is a passing score
Exam fee
$1490 (rates for examinations administered beginning August 2026)
Examination outline
  • ANATOMY (Gross, Neuroanatomy, Histology, Developmental) — 12% - 18% of scored items (42 - 62 items)
    • Anatomy (Gross): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — A. Eyelid; 1. Anatomic boundaries; 2. Layers; 3. Muscles (actions); 4. Glands (secretions, functions); 5. Blood supply and drainage, lymphatic drainage; 6. Innervation
    • Anatomy (Gross): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — B. Eyebrow (structure and function)
    • Anatomy (Gross): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — C. Lacrimal system; 1. Lacrimal gland (structure, innervation, blood supply); 2. Accessory lacrimal glands (location, function); 3. Distribution of tears (role of eyelids); 4. Drainage of tears; nasolacrimal duct (cellular lining); lacrimal papillae (location); lacrimal puncta; canaliculi (relationship to Horner muscle); lacrimal sac (relationship to medial palpebral ligament, Horner muscle, orbicularis oculi; septum orbitale); 5. Lacrimal fossa (bony structure); 6. Nasolacrimal canal (bony composition, relationship to maxillary sinus)
    • Anatomy (Gross): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — D. Orbit; 1. Contents (extraocular muscles, nerves, blood vessels, fat compartments, fascia); 2. Anatomical relationships among orbital structures; 3. Bones of the orbit; 4. Foramina and openings of the orbit (location, contents)
    • Anatomy (Gross): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — E. Extraocular muscles; 1. Names; 2. Origins; 3. Insertions; 4. Innervations, blood supply; 5. Relationship to other orbital structures
    • Anatomy (Gross): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — F. Blood supply; 1. Branches of internal and external carotid arteries related to the orbit, eyelid, and upper face; 2. Branches of the internal and external jugular veins; 3. Dural sinuses
    • Anatomy (Gross): Conjunctiva / Cornea / Refractive Surgery — A. Cornea; 1. Normal dimensions including diameter, radii of curvature (anterior and posterior) and thickness (central and peripheral); 2. Epithelium (histology and ultrastructure); 3. Basal lamina (relationship to epithelium); 4. Anterior limiting lamina (Bowman layer): relationship to stroma, basal lamina, and epithelium; 5. Stroma (composition, ultrastructure); 6. Posterior limiting lamina (Descemet membrane): relationship to stroma and endothelium; 7. Endothelium (composition, ultrastructure); 8. Limbus; 9. Innervation; 10. Regeneration
    • Anatomy (Gross): Conjunctiva / Cornea / Refractive Surgery — B. Conjunctiva; 1. Location; 2. Composition (layers, cell types, glands, Palisades of Vogt); 3. Relationship to tarsal plate, extraocular muscles, sclera, fascia, bulbi (Tenon capsule), cornea; 4. Blood supply and venous drainage, lymphatic drainage; 5. Innervation; 6. Plica semilunaris (composition); 7. Caruncle (composition)
    • Anatomy (Gross): Lens / Cataract / IOL / Pre- & Post-Operative Care — A. Lens, zonule; 1. Zonule; 2. Location of lens; 3. Epithelium (capsule, ultrastructure); 4. Cortex (composition of lens fibers, ultrastructure); 5. Nuclei (various names and locations); 6. Sutures (location)
    • Anatomy (Gross): Episclera / Sclera / Anterior Uvea — A. Sclera; 1. Size; 2. Radius of curvature; 3. Thickness; 4. Color; 5. Relationship to conjunctiva, Tenon capsule, suprachoroidal space; 6. Emissaria (contents, location); 7. Composition; 8. Lamina cribrosa (structure)
    • Anatomy (Gross): Episclera / Sclera / Anterior Uvea — B. Anterior chamber and angle; 1. Shape and volume; 2. Boundaries; 3. Diameter and depth; 4. Trabecular meshwork (components, ultrastructure); 5. Juxtacanalicular tissue (components, ultrastructure); 6. Schlemm canal (location, size, ultrastructure of wall, afferent and efferent connections); 7. Scleral spur (composition, location); 8. Schwalbe line (composition, location)
    • Anatomy (Gross): Episclera / Sclera / Anterior Uvea — C. Iris; 1. Gross landmarks, zones; 2. Diameter; 3. Coloration (factors controlling); 4. Anterior border (composition, ultrastructure); 5. Stroma (composition); 6. Sphincter muscle (type, composition, innervation); 7. Anterior epithelium (ultrastructure); 8. Dilator muscle (type, composition, innervation); 9. Posterior epithelium (relationship to lens, anterior, epithelium, pupil margin); 10. Blood supply, venous drainage; 11. Innervation; 12. Size and location of pupil
    • Anatomy (Gross): Episclera / Sclera / Anterior Uvea — D. Posterior chamber; 1. Size and volume; 2. Boundaries
    • Anatomy (Gross): Episclera / Sclera / Anterior Uvea — E. Ciliary body; 1. Gross morphology; 2. Dimensions; 3. Relationships to sclera, anterior chamber, iris, posterior chamber, lens, and retina; 4. Pars plana (location, components); 5. Pars plicata (location, components); 6. Stroma (components); 7. Ciliary muscle (components, relations, actions, innervation); 8. Pigmented epithelium (basal lamina, ultrastructure); 9. Non-pigmented epithelium (basal lamina, ultrastructure, relationship to pigmented epithelium); 10. Blood supply and venous drainage; 11. Innervation
    • Anatomy (Gross): Vitreous / Retina / Choroid — A. Choroid; 1. Extent; 2. Thickness; 3. Relationship to lamina fusca of sclera; 4. Choriocapillaris (ultrastructure, type of capillaries); 5. Stroma; 6. Blood supply; 7. Venous drainage; 8. Innervation; 9. Bruch membrane (location, composition)
    • Anatomy (Gross): Vitreous / Retina / Choroid — B. Vitreous; 1. Volume; 2. Shape; 3. Attachments to retina and lens (ultrastructure); 4. Patellar fossa (location); 5. Anterior hyaloid (location); 6. Posterior hyaloid (location); 7. Cortex (composition); 8. Hyaloid canal (location, origin)
    • Anatomy (Gross): Vitreous / Retina / Choroid — C. Retina; 1. Layers (components of each ultrastructure); 2. Relationship between retinal pigment epithelium and Bruch membrane; 3. Relationship between retinal pigment epithelium and photoreceptor outer segments; 4. Synaptic connections within retina; 5. Glial cells (name, location, function); 6. Blood supply; 7. Anatomical areas (location, size, composition) of area centralis, parafovea, fovea, foveola, macula lutea, ora serrata (ultrastructure)
    • Anatomy (Gross): Optic Nerve / Neuro-Ophthalmic Pathways — A. Ocular and orbital nerves; 1. Cranial nerves I, III, IV, V, VI, VII (intracranial and extracranial course, branches, functions, tissue innervated); 2. Parasympathetic nerves (course, branches, tissue innervated); 3. Sympathetic nerves (course, branches, tissue innervated)
    • Anatomy (Gross): Optic Nerve / Neuro-Ophthalmic Pathways — B. Optic nerve; 1. Surface features; 2. Prelaminar portion (composition, blood supply); 3. Laminar portion (composition, blood supply); 4. Retrolaminar portion (composition, blood supply); 5. Central retinal artery and vein (location); 6. Optic disc/cup
    • Anatomy (Gross): Optic Nerve / Neuro-Ophthalmic Pathways — C. Visual pathway; 1. Localization of retinal fibers along visual pathway: optic nerve, chiasm, optic tract, lateral geniculate body, optic radiations, visual cortex; 2. Layers of lateral geniculate body (afferents, efferents); 3. Layers and areas of visual cortex; 4. Blood supply; 5. Anatomy related to visual pathology
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — A. Anterior chamber and angle
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — B. Ciliary body
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — C. Choroid
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — D. Vitreous
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — E. Retina
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — F. Optic nerve
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — G. Cornea
    • Anatomy (Gross): Glaucoma — Gross Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma (e.g., pigmentary dispersion glaucoma, pseudoexfoliation glaucoma, etc.) — H. Lens
    • Anatomy (Gross): Systemic Health — A. Head and neck; 1. Skull (e.g., bones, sutures, fossae, foramina); 2. Superficial and deep arteries, veins, and lymphatics; 3. Muscles of facial expression and mastication; 4. Muscles of the neck; 5. Peripheral nerve distributions; 6. Cervical triangles and their contents, root of neck, thyroid and parathyroid glands; 7. Salivary glands; 8. Nose; 9. Paranasal sinuses and their relations to the orbit and orbital contents; 10. Ear (e.g., outer ear, middle ear, walls, muscles, inner ear); 11. Dural venous sinuses; meninges; cerebrospinal fluid
    • Anatomy (Gross): Systemic Health — B. Thorax; 1. Lungs (e.g., lobes); 2. Pulmonary circulation; 3. Heart (e.g., surfaces); 4. Superior mediastinum (e.g., trachea, esophagus)
    • Anatomy (Gross): Systemic Health — C. Abdomen/Pelvis; 1. Liver (e.g., concept of portal system); 2. Accessory digestive organs (e.g., gallbladder, pancreas); 3. Other internal organs (e.g., spleen, kidney); 4. Gastrointestinal system (e.g., stomach)
    • Anatomy (Gross): Systemic Health — D. Systemic circulation of blood and lymph
    • Anatomy (Neuroanatomy): Systemic Health — A. Spinal cord; 1. Gray matter (e.g., nuclei, local reflex arcs); 2. White matter (e.g., ascending pathways, descending pathways); 3. Spinal nerves and sensory ganglia
    • Anatomy (Neuroanatomy): Systemic Health — B. Autonomic nervous system; 1. Parasympathetic (course, branches, functions, tissue innervated); 2. Sympathetic (course, branches, functions, tissue innervated); 3. Neurotransmitters (e.g., types, locations)
    • Anatomy (Neuroanatomy): Systemic Health — C. Medulla; 1. Level of motor decussation; 2. Level of sensory decussation; 3. Level of inferior olives; 4. Level of open medulla; 5. Dorsal and ventral cochlear nuclei; 6. Vestibular nuclei; 7. Glossopharyngeal nerve; 8. Vagus nerve; 9. Spinal accessory nerve; 10. Hypoglossal nerve
    • Anatomy (Neuroanatomy): Systemic Health — D. Pons; 1. Low or caudal pons; 2. Abducens nerve; 3. Mid pons; 4. Trigeminal nerve; 5. Facial nerve; 6. Vestibulocochlear nerve
    • Anatomy (Neuroanatomy): Systemic Health — E. Midbrain; 1. Level of inferior colliculus; 2. Trochlear nerve; 3. Level of superior colliculus; 4. Oculomotor nerve; 5. Level of pretectum (e.g., light reflex)
    • Anatomy (Neuroanatomy): Systemic Health — F. Diencephalon; 1. Dorsal thalamus; 2. Hypothalamus; 3. Epithalamus; 4. Subthalamus
    • Anatomy (Neuroanatomy): Systemic Health — G. Cerebrum; 1. Gray matter (e.g., cytoarchitecture (layers), Brodmann cortical areas); 2. White matter (e.g., projections, internal capsule, optic radiations, commissural fibers, associational fibers); 3. Functions
    • Anatomy (Neuroanatomy): Systemic Health — H. Cerebellum
    • Anatomy (Neuroanatomy): Systemic Health — I. Blood supply; 1. Surface arteries; 2. Circle of Willis and its branches
    • Anatomy (Histology): Systemic Health — A. Generalized cell; 1. Molecular components, unit membrane; 2. Organelles (e.g., plasma membrane, endoplasmic reticulum); 3. Inclusions (e.g., pigments); 4. Nucleus; 5. Cytoskeleton (e.g., microtubules)
    • Anatomy (Histology): Systemic Health — B. Tissue types; 1. Epithelium; a. Lining epithelium; i. Simple, stratified, pseudostratified; ii. Squamous, cuboid, columnar; iii. Surface specializations (e.g., microvilli); iv. Cell junctions (e.g., zonula occludens); v. Basal lamina; b. Secretory epithelium; i. Unicellular vs. multicellular; ii. Exocrine, endocrine, paracrine, autocrine; iii. Secretory unit, mode of secretion; iv. Connective tissue element; 2. Connective tissue; a. Connective tissue proper; i. Types: dense, loose, elastic, reticular; ii. Cells; iii. Fibers (e.g., collagen); iv. Matrix; b. Specialized connective tissues; i. Blood; a. Plasma; b. Cells; c. Platelets; ii. Bone; iii. Cartilage and synovial joints; iv. Fat: multilocular, unilocular; 3. Muscle; a. Smooth; b. Striated; c. Cardiac; d. Receptors (e.g., muscle spindles); 4. Nervous tissue; a. Neuron; b. Ganglia; c. Neural coverings (e.g., myelin, perineurium); d. Neuroglia; e. Synapse; f. Terminals
    • Anatomy (Histology): Systemic Health — C. Organ systems; 1. Integumentary system; a. Skin (e.g., layers, cell types, hair); b. Cutaneous glands: sebaceous, sweat; c. Receptors; i. Free nerve endings; ii. Encapsulated nerve endings (e.g., Pacinian corpuscles); 2. Cardiovascular system; a. Heart; i. Tissue layers; ii. Valves; iii. Conduction system; b. General histology of blood vessels; i. Capillaries; ii. Arteries; iii. Arterioles; iv. Veins; 3. Lymphatic system; a. Lymph vessels; b. Lymph nodes; c. Spleen; d. Thymus; e. Tonsils; f. Lymphatic tissue associated with mucous membrane; 4. Respiratory system; a. Nose; b. Paranasal air sinuses; c. Nasopharynx; d. Larynx; e. Trachea; f. Lungs; g. Blood vessels associated with the respiratory system; 5. Digestive system; a. Oral cavity; b. Esophagus; c. Stomach; d. Small intestine; e. Large intestine; f. Salivary glands; g. Pancreas; h. Liver, gallbladder; i. Blood vessels associated with the digestive system; 6. Urinary system; a. Kidney; b. Ureter, bladder, urethra; c. Blood vessels associated with the urinary system; 7. Endocrine system; a. Thyroid; b. Islets of Langerhans; c. Pituitary; d. Adrenal gland; e. Gonads
    • Anatomy (Histology): Systemic Health — D. Neurohistology; 1. Neural plate, neural fold, neural groove, neural tube, neural vesicles; 2. Derivatives of neural crest (e.g., ganglia, adrenal medulla); 3. Layers of neural tube (e.g., ependymal, mantle, marginal); 4. Degeneration and regeneration in the nervous system
    • Anatomy (Developmental): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — A. Orbit; 1. Development of bones of orbit (closure of sutures); 2. Abnormalities (faulty development of facial bones)
    • Anatomy (Developmental): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — B. Extraocular muscles; 1. Condensation of mesenchyme (bilateral condensation); 2. Motor innervation development; 3. Insertion of extraocular primordia into anterior sclera; 4. Late development
    • Anatomy (Developmental): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — C. Eyelid; 1. Tissue origin; 2. Lid folds; 3. Fusion of eyelid; 4. Ectodermal derivatives (skin, glands, conjunctiva); 5. Mesodermal derivatives (tarsus, orbital septum, orbicularis oculi, aponeurosis of levator, smooth muscle)
    • Anatomy (Developmental): Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — D. Lacrimal apparatus; 1. Tissue origin of lacrimal glands (main, accessory); 2. Tissue origin of lacrimal and nasal passages; 3. Abnormalities
    • Anatomy (Developmental): Conjunctiva / Cornea / Refractive Surgery — A. Conjunctiva; 1. Ectodermal specialization forming conjunctiva and glands
    • Anatomy (Developmental): Conjunctiva / Cornea / Refractive Surgery — B. Cornea; 1. Inductive mechanisms; 2. Ectodermal components (epithelium, primary stroma); 3. Mesenchymal components (waves); 4. Corneal nerve development (origin); 5. Factors affecting corneal size, curvature, transparency
    • Anatomy (Developmental): Lens / Cataract / IOL / Pre- & Post-Operative Care — A. Lens, zonules; 1. Zonules development; 2. Tissue origin; 3. Tissue induction and interaction (effect on development of vitreous, iris, cornea, retina); 4. Mechanism of lens fiber orientation; 5. Stages of lens development (lens placode, lens pit, lens vesicles); 6. Stages of lens fiber development; 7. Development nuclei (embryonic, fetal, infantile); 8. Zones of development of lens epithelium
    • Anatomy (Developmental): Episclera / Sclera / Anterior Uvea — A. Sclera; 1. Inductive mechanisms; 2. Tissue origin; 3. Comparison with cornea
    • Anatomy (Developmental): Episclera / Sclera / Anterior Uvea — B. Anterior chamber and angle; 1. Creation of anatomical space; 2. Factors that promote growth of anterior chamber; 3. Creation of angle (atrophy theory, cleavage theory, reorganization theory, rarefaction theory); 4. Differentiation of Schlemm canal, scleral spur, trabecular meshwork; 5. Endothelial membrane
    • Anatomy (Developmental): Episclera / Sclera / Anterior Uvea — C. Iris/Pupil; 1. Development of iris stroma (anterior leaf, posterior leaf); 2. Development of pars iridica retinae (epithelial layer); 3. Development of dilator and sphincter muscles; 4. Pupillary membrane (atrophy); 5. Cilio-iridic circulation; 6. Development of iris pigmentation
    • Anatomy (Developmental): Episclera / Sclera / Anterior Uvea — D. Posterior chamber
    • Anatomy (Developmental): Episclera / Sclera / Anterior Uvea — E. Ciliary body; 1. Tissue origin (mesoderm, neural crest); 2. Development of pars ciliaris retinae (epithelial layers); 3. Development of ciliary processes, ciliary muscles, ciliary vessels
    • Anatomy (Developmental): Vitreous / Retina / Choroid — A. Choroid; 1. Tissue origin (paraxial mesoderm, neural crest cells); 2. Development of choroidal vasculature (3 stages); 3. Development of Bruch membrane
    • Anatomy (Developmental): Vitreous / Retina / Choroid — B. Vitreous; 1. Primary vitreous (hyaloid canal, tissue origin, tissue characteristics); 2. Secondary vitreous (tissue origin, tissue characteristics); 3. Tertiary vitreous (tissue origin, tissue characteristics, hyaloid vasculature remnants)
    • Anatomy (Developmental): Vitreous / Retina / Choroid — C. Retina; 1. Development of optic cup; 2. Analogies between development of retina and central nervous system; 3. Fetal fissure (formation, function, fusion, failure to fuse); 4. Retinal differentiation (stages I, II, III, proliferation, migration, differentiation); 5. Macular differentiation; 6. Retinal circulation development (hyaloid system, central retinal artery/vein, hyaloid vasculature remnants); 7. Postnatal events
    • Anatomy (Developmental): Optic Nerve / Neuro-Ophthalmic Pathways — A. Optic nerve and visual pathway; 1. Developmental stages of lower visual pathway, before lateral geniculate body (differences crossed and uncrossed fibers); 2. Myelination of the visual pathway (lower visual pathways vs. upper visual pathway); 3. Relationship between development of upper visual pathway and central vision; 4. Physiological cupping
    • Anatomy (Developmental): Glaucoma — Developmental Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma — A. Anterior chamber and angle; 1. Creation of anatomical space; 2. Factors that promote growth of anterior chamber; 3. Creation of angle (atrophy theory, cleavage theory, reorganization theory, rarefaction theory); 4. Differentiation of Schlemm canal, scleral spur, trabecular meshwork; 5. Endothelial membrane
    • Anatomy (Developmental): Glaucoma — Developmental Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma — B. Iris/Pupil; 1. Development of iris stroma (anterior leaf, posterior leaf); 2. Development of pars iridica retinae (epithelial layer); 3. Development of dilator and sphincter muscles; 4. Pupillary membrane (atrophy); 5. Cilio-iridic circulation; 6. Development of iris pigmentation
    • Anatomy (Developmental): Glaucoma — Developmental Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma — C. Ciliary body; 1. Tissue origin (mesoderm, neural crest); 2. Development of pars ciliaris retinae (epithelial layers); 3. Development of ciliary processes, ciliary muscles, ciliary vessels
    • Anatomy (Developmental): Glaucoma — Developmental Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma — D. Retina; 1. Development of optic cup; 2. Analogies between development of retina and central nervous system; 3. Fetal fissure (formation, function, fusion, failure to fuse); 4. Retinal differentiation (stages I, II, III, proliferation, migration, differentiation); 5. Macular differentiation; 6. Retinal circulation development (hyaloid system, central retinal artery/vein, hyaloid vasculature remnants); 7. Postnatal events
    • Anatomy (Developmental): Glaucoma — Developmental Anatomy of the eye as it relates to primary open-angle glaucoma, angle-closure glaucoma, and secondary glaucoma — E. Optic nerve and visual pathway; 1. Developmental stages of lower visual pathway, before lateral geniculate body (differences between crossed and uncrossed fibers); 2. Myelination of the visual pathway (lower visual pathway vs. upper visual pathway); 3. Relationship between development of upper visual pathway and central vision; 4. Physiological cupping
  • BIOCHEMISTRY / PHYSIOLOGY — 10% - 14% of scored items (35 - 49 items)
    • Biochemistry: Systemic Health — A. Cellular biochemistry; 1. Compartmentalization; 2. Cell organelles; 3. Intracellular/extracellular; 4. Cell communication; 5. Bonds and molecular interactions
    • Biochemistry: Systemic Health — B. Proteins; 1. Structure and types; a. Alpha amino acids, peptide bond; b. Primary, secondary, tertiary, and quaternary structure; c. Multimers; d. Globular/fibrous; e. Enzymes; f. Antibodies; g. Connective-tissue/collagen; h. Hemoglobins; 2. Mechanism of enzyme action; a. Biocatalysis; b. Activation energy; c. Michaelis-Menten model (e.g., Michaels-Menten equation, Lineweaver-Burk plot); d. Allosteric interaction/positive and negative feedback modulation; e. Reversible covalent modification/enzyme cascades; f. Proteolytic activation; g. Stimulation and inhibition by control/regulatory proteins
    • Biochemistry: Systemic Health — C. Bioenergetics and energy storage; 1. Free energy/entropy/enthalpy/equilibrium; 2. Endergonic, exergonic, and coupled reactions; 3. Oxidation-reduction; 4. pH and Henderson-Hasselbalch equation, biological buffers; 5. ATP and other nucleotide phosphates; 6. NADH and FADH; 7. NADPH; 8. Acetyl CoA
    • Biochemistry: Systemic Health — D. Carbohydrate biochemistry; 1. Structure and function; a. Monosaccharides, oligosaccharides, polysaccharides; b. Glycosaminoglycans; c. Proteoglycans; d. Glycoproteins; 2. Glycolysis/glucose metabolism; 3. TCA cycle; 4. Pentose phosphate pathway; 5. Gluconeogenesis; 6. Glycogen synthesis, storage, and breakdown/utilization; 7. Electron transport system and oxidative phosphorylation; a. Mitochondrial structure/function/DNA; b. Electron transport/pH coupling
    • Biochemistry: Systemic Health — E. Lipid biochemistry; 1. Structure and function; a. Fatty acids/eicosanoids; b. Triacylglycerols; c. Phosphoglycerides; d. Sphingolipids; e. Sterol derivatives; f. Isoprenoids; 2. Digestion, absorption, and transport of lipids (e.g., types of lipoproteins); 3. Fatty acid metabolism (e.g., beta-oxidation, ketone bodies, gluconeogenesis); 4. Cholesterol and steroid metabolism; 5. Membrane biochemistry; a. Unit membrane/lipid bilayer; b. Fluid mosaic model; c. Membrane proteins and lipids/structure and function
    • Biochemistry: Systemic Health — F. Molecular biology; 1. DNA structure and function; a. Deoxynucleotides and synthesis; b. Base pairing/double helix; c. Genetic code/introns, exons; d. Chromosome structure; 2. RNA Structure and function; a. Ribonucleotides and synthesis; b. Messenger RNA synthesis and function; c. Ribosomal RNA synthesis and function; d. Transfer RNA synthesis and function; 3. DNA replication; 4. Protein synthesis; a. Ribosome function; b. Initiation, elongation, and termination; c. Post-translational medication/protein sorting; 5. Gene expression and regulation; 6. Mutations and repair; 7. Oncogenes/proto-oncogenes/tumor suppressor genes; 8. Tools of recombinant DNA technology (e.g., polymerase chain reaction, chromosome analysis, Southern blot); 9. Molecular therapy (e.g., gene therapy, anti-sense therapy); 10. Cell cycle; 11. Genomics; 12. Proteomics; 13. Apoptosis
    • Biochemistry: Systemic Health — G. Nutrition; 1. Digestion of proteins, carbohydrates, and lipids; 2. Essential amino acids; 3. Vitamins; a. Classification; b. Functions; 4. Minerals; 5. Oxygen toxicity/antioxidants/control of free radicals, peroxide, and superoxides
    • Physiology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — A. Eyelids; 1. Normal closure of eyelids (forced, spontaneous); 2. Blink reflexes (spontaneous, menace, auditory, touch, dazzle); 3. Role of eyelids in production, distribution, and drainage of tears; 4. Protective functions of eyelids; 5. Purposes and roles for vision
    • Physiology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — B. Tears and lacrimal apparatus; 1. Functions of tears; 2. Production of tears; a. Sources; b. Neural control; 3. Composition of tears; a. Electrolytes; b. Low molecular weight organics (glucose, amino acids); c. High molecular weight organics (proteins, lipids, glycoproteins); d. Cells; e. Physiological variations (e.g., aging, opening vs. closed eyes, contact lens wear) in tear constituents; 4. Tear film distribution, structure, and stability; 5. Elimination of tears:; a. Nasolacrimal drainage apparatus; b. Evaporation and absorption; 6. Physico-chemical properties of tears:; a. Osmotic pressure; b. pH and buffering; c. Temperature and viscosity
    • Physiology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — C. Extraocular muscles; 1. Vestibular control mechanisms; 2. Supranuclear control of eye movements; 3. Agonist-antagonist relationships; 4. Primary, secondary, and tertiary actions; 5. Fields of action; 6. Conduction and contraction
    • Physiology: Conjunctiva / Cornea / Refractive Surgery — A. Cornea; 1. Physical characteristics (water content, protein content, cells, resistance to trauma); 2. Permeability characteristics of various layers; 3. Metabolic characteristics of various layers; 4. Theories of corneal transparency; 5. Factors influencing corneal thickness/hydration (osmolarity of tears, integrity of epithelium and endothelium, epithelial and endothelial pumps); 6. Physiological parameters necessary to maintain corneal integrity (oxygen level, glucose level, pH, etc.); 7. Epithelial regeneration (normal and response to trauma); 8. Physiological characteristics of corneal nerves; 9. Aging changes of the cornea; 10. Corneal hysteresis
    • Physiology: Lens / Cataract / IOL / Pre- and Post-Operative Care — A. Lens; 1. Functions of lens; 2. Composition of lens; 3. Difference in composition between lens and aqueous; 4. Metabolism of lens (various pathways essential to the lens); 5. Types of lens proteins; 6. Factors which regulate size and solubility of lens proteins (vitamin C, glutathione); 7. Theories of lens transparency; 8. Mitotic activity of lens epithelium; 9. Aging changes in composition of the lens
    • Physiology: Episclera / Sclera / Anterior Uvea — A. Uvea; 1. Functions of ciliary body; 2. Functions of iris; 3. Functions of choroid; 4. Uveal blood flow: choroid, ciliary body, iris (unique characteristics of each, functions of each)
    • Physiology: Vitreous / Retina / Choroid — A. Vitreous; 1. Functions; 2. Compositions; 3. Metabolism; 4. Aging changes in composition; 5. Physical characteristics (volume, water content, transparency)
    • Physiology: Vitreous / Retina / Choroid — B. Retina; 1. Composition of disc outer segments; 2. Formation of disc outer segments (disc renewal, disc shedding); 3. Composition of visual pigments; 4. Formation of visual pigments; 5. Stages of visual cycle; 6. Photoreceptor electrophysiology (membrane potentials, dark current role of sodium, calcium, etc.); 7. Retinal neurotransmitters; 8. Function of bipolar, horizontal, amacrine and ganglion cells (receptive fields); 9. Retinal neural mechanisms of color vision (spatial, temporal, and chromatic); 10. Physiological relationship in the choroid and the retina, including retinal metabolism; 11. Retinal blood flow (unique characteristics, dual supply, functions)
    • Physiology: Optic Nerve / Neuro-Ophthalmic Pathways — A. Neurophysiology; 1. Integration of nerve signals (e.g., synaptic processes, reflexes, feedback, adaptation, and habituation); 2. Sensory coding (e.g., receptive field concept); 3. Somatosensory system; 4. Auditory system; 5. Vestibular system; 6. Motor pathways; 7. Autonomic nervous systems; 8. Significance of evoked potentials, CT and PET scanning, and MRI; 9. Plasticity
    • Physiology: Optic Nerve / Neuro-Ophthalmic Pathways — B. Visual pathway; 1. Function of lateral geniculate body; 2. Receptive fields of cells in lateral geniculate body (relationship to color vision, binocularity, space perception, etc.); 3. Function of visual cortex; 4. Receptive field properties (single cell properties); 5. Functional organization; 6. Physiology of binocular vision; 7. Mechanism of feature detection; 8. Gross electrical potentials; a. EOG; b. ERG; c. VEP (VER)
    • Physiology: Optic Nerve / Neuro-Ophthalmic Pathways — C. Pupillary pathways; 1. Sympathetic pathways to iris; 2. Parasympathetic pathway to iris; 3. Functional relationships between pupillary pathways and central nervous system
    • Physiology: Glaucoma — A. Intraocular pressure; 1. Methods of measurement; 2. Normative values; 3. Factors controlling aqueous production and outflow; 4. Nervous system regulation of IOP; 5. Factors influencing IOP (body position, corneal thickness, blood pressure); 6. Corneal hysteresis
    • Physiology: Glaucoma — B. Aqueous; 1. Functions of aqueous; 2. Volume, osmolarity, viscosity; 3. Formation (ultrafiltration, active transport); 4. Factors influencing rate of flow; 5. Composition; 6. Blood aqueous barriers (location, ultrastructure, function)
    • Physiology: Systemic Health — A. Cellular functions; 1. Cytoplasm and cytoskeleton (e.g., microtubules, microfilaments); 2. Functions of organelles (e.g., endoplasmic reticulum); 3. Intracellular and extracellular environment; 4. Membrane potential and transport mechanisms; 5. Membrane receptors and postreceptor events
    • Physiology: Systemic Health — B. Respiration; 1. Mechanics of breathing; 2. Gas exchange in the lungs; 3. Diffusion of oxygen and carbon dioxide; 4. Oxygen transport and hypoxia, carbon dioxide transport; 5. Regulation of respiratory rate; 6. Acid-base balance
    • Physiology: Systemic Health — C. Gastrointestinal activity; 1. Absorption; 2. Motility; 3. Nervous and hormonal regulation; 4. Associated structures (e.g., liver, pancreas, salivary glands)
    • Physiology: Systemic Health — D. Muscle; 1. Neuromuscular junctions; 2. Conduction and contraction; 3. Types of contraction (e.g., isometric, isotonic); 4. Reflex arc (e.g., muscle spindles, Golgi tendon organ); 5. Smooth muscle
    • Physiology: Systemic Health — E. Body fluids; 1. Composition of body fluids; 2. Control systems of the body (e.g., exchange of water and electrolytes between body compartments); 3. Regulation of volume and osmolarity of extracellular fluid
    • Physiology: Systemic Health — F. Renal system and body fluids; 1. Nephron, tubular reabsorption, and secretion; 2. Regulation of glomerular filtration; 3. Functional characteristics of renal blood vessels; 4. Renal regulatory mechanisms; 5. Renal control of blood pressure and water balance; 6. Renal control of plasma sodium and potassium levels; 7. Regulation of acid-base balance
    • Physiology: Systemic Health — G. Circulatory system; 1. Mechanical events of cardiac cycle; 2. Electrical activity of the heart (e.g., pacemaker potentials, action potentials, and spread of the activity); 3. Significance of EKG; 4. Hemodynamics (e.g., pressure and resistance relationships); 5. Regulation of blood flow and pressure (e.g., autonomic); 6. Lymph formation and function; 7. Blood and its functions (e.g., hemostasis); 8. Hemodynamic patterns (resistance, transmural pressure, flow rate, critical closing pressures); 9. Autoregulation; 10. Autonomic nervous system control
    • Physiology: Systemic Health — H. Endocrine system; 1. Hormones (e.g., synthesis, mechanism of action); 2. Hypothalamic control of pituitary gland; 3. Pituitary control of endocrine glands; 4. Functions and regulations of adrenal cortex (e.g., glucocorticoids, mineral corticoids); 5. Functions and regulation of adrenal medulla (e.g., epinephrine); 6. Functions and regulation of thyroid gland (e.g., TSH, T3, T4); 7. Functions and regulations of pancreatic insulin and glucagon; 8. Regulation of blood sugar levels; 9. Functions and regulation of vitamin D, parathyroid hormone, and calcitonin; 10. Functions and regulation of endorphin, enkephalin and growth hormone blood levels
    • Physiology: Systemic Health — I. Reproductive system; 1. Functions and regulation of reproductive hormones; 2. Pregnancy, birth, and lactation
    • Physiology: Systemic Health — J. Electrophysiology and the nerve cell; 1. Basis of resting potential (e.g., ionic balance, transport mechanisms); 2. Basis of action potential (e.g., ionic balance); 3. Action potential conduction; 4. Synapses, classification, transmission, neurotransmitters; 5. Membrane physiology, receptors, membrane channels; 6. Inhibitory and excitatory postsynaptic potentials (including concepts of spatial and temporal summation); 7. Strength-duration curve
  • IMMUNOLOGY / MICROBIOLOGY / PATHOLOGY — 22% - 30% of scored items (77 - 105 items)
    • Immunology: Systemic Health — A. Antigens, chemistry and origin
    • Immunology: Systemic Health — B. Antibodies; 1. Chemical structure; 2. Classification; 3. Immunological functions; 4. Genetics/clonal selection
    • Immunology: Systemic Health — C. Antigen-antibody interactions
    • Immunology: Systemic Health — D. Complement chemistry, function and pathways
    • Immunology: Systemic Health — E. Cytokines, origin and function
    • Immunology: Systemic Health — F. Nonspecific immunity; 1. Anatomical barriers; 2. Phagocytic cell types and inflammation; 3. Role of complement and antibody; 4. Interferon, lysozyme; 5. Natural killer cells
    • Immunology: Systemic Health — G. Specific immunity; 1. Cell types, markers, and function; 2. Cell-cell interactions in the immune response; 3. Humoral immunity; 4. Cellular immunity; 5. Primary and secondary immune responses
    • Immunology: Systemic Health — H. Tissue transplantation and graft rejection (mechanisms)
    • Immunology: Systemic Health — I. Autoimmunity
    • Immunology: Systemic Health — J. Tumor immunology
    • Microbiology: Systemic Health — A. Bacteriology; 1. Eukaryotic vs. prokaryotic cells; 2. Bacterial cell structures and cell wall morphology; a. Biochemical composition; b. Gram (+) vs. Gram (-) characteristics; c. Function in pathogenesis; 3. Physiological processes of bacterial growth; a. Life cycle; b. Anaerobic vs. aerobic; c. Spore formation; 4. Genetic mechanisms of bacteria; 5. Normal body flora; 6. Disease states, transmission, pathogenic mechanisms, symptoms, diagnosis, and immunity of infections by:; a. Gram (+) and Gram (-) cocci and rods; b. Spirochetes; c. Actinomycetes; d. Mycobacteria; e. Chlamydia; f. Rickettsia; g. Mycoplasma; 7. Laboratory isolation, culture, and identification of bacteria; 8. Procedures for antibiotic susceptibility testing; 9. Quality control/sterilization and disinfection
    • Microbiology: Systemic Health — B. Virology; 1. Virus particle chemistry and morphology; 2. Classification scheme for viruses; a. DNA vs. RNA types; b. Double-stranded vs. single-stranded; c. Envelopes; 3. Genetic mechanisms of viruses; 4. Viral replication in host cells; a. DNA and RNA viruses, with or without envelopes; 5. Disease states, transmission, pathogenic mechanisms, symptoms, diagnosis, and immunity of infections by viruses; 6. Laboratory isolation, culture, and identification of viruses; 7. Virus-like structures (e.g., prions)
    • Microbiology: Systemic Health — C. Mycology; 1. Biology of fungi; a. Yeast and mold morphology; b. Asexual and sexual reproduction/structures; 2. Disease states, transmission, pathogenic mechanisms, symptoms, diagnosis, and immunity of infections by:; a. Superficial mycoses; b. Cutaneous mycoses; c. Subcutaneous mycoses; d. Systemic mycoses; e. Opportunistic yeasts and molds; 3. Laboratory isolation, culture, and identification of fungi
    • Microbiology: Systemic Health — D. Parasitology; 1. Disease states, life cycles, transmission, pathogenic mechanisms, symptoms, diagnosis, and immunity of infections by protozoans, trematodes, cestodes, nematodes and arthropods; 2. Laboratory identification of parasites
    • Pathology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — A. Orbit, adnexa, lacrimal system; 1. Epidemiology, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic testing (applications and interpretations); 4. Pathophysiology and diagnosis
    • Pathology: Conjunctiva / Cornea / Refractive Surgery — A. Cornea/External Disease; 1. Epidemiology, genetics, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic and genetic testing (applications and interpretations); 4. Pathophysiology and diagnosis; 5. Contact lens selection and post-fitting complications; 6. Corneal surgery and procedures:; a. Refractive (e.g., LASIK, PRK, SMILE, intracorneal ring segments); b. Non-refractive (e.g., penetrating keratoplasty, DMEK, DSAEK, cross-linking, superficial keratectomy)
    • Pathology: Lens / Cataract / IOL / Pre- and Post-Operative Care — A. Lens/Cataract; 1. Epidemiology, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic testing (applications and interpretations); 4. Pathophysiology and diagnosis:; a. Cataract as a manifestation of ocular and systemic disease; 5. Cataract and clear lens extraction surgery:; a. Indications; b. Pre-operative measures; c. Intraocular lens selection; d. Procedure; e. Complications; 6. YAG capsulotomy:; a. Indications; b. Procedure; c. Complications
    • Pathology: Episclera / Sclera / Anterior Uvea — A. Uvea, Sclera/Episclera; 1. Epidemiology, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic testing (applications and interpretations); 4. Pathophysiology and diagnosis
    • Pathology: Vitreous / Retina / Choroid — A. Retina/Vitreous; 1. Epidemiology, genetics, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic and genetic testing (applications and interpretations); 4. Pathophysiology and diagnosis
    • Pathology: Optic Nerve / Neuro-Ophthalmic Pathways — A. Neuro-Ophthalmic disorders; 1. Epidemiology, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic testing (applications and interpretations); 4. Pathophysiology and diagnosis
    • Pathology: Glaucoma — A. Glaucoma; 1. Epidemiology, history, and symptom inventory; 2. Observation, inspection, recognition of signs, and techniques and skills; 3. Diagnostic testing (applications and interpretations); 4. Pathophysiology and diagnosis; 5. Glaucoma surgery:; a. Indications; b. Mechanisms; c. Co-management
    • Pathology: Systemic Health — A. General health; 1. Epidemiology; 2. Detailed history with regards to differential diagnosis of fatigue, weight loss, fever, headache, dizziness, and malaise; 3. Presentations involving abnormal body habitus and demeanor; 4. Physical developmental norms and standards for all ages; 5. Common systemic side effects of medications; 6. Principles of basic cardiac life support; 7. Preventive medicine; 8. Medical laboratory tests for screening; 9. Diagnostic testing and imaging; 10. Pathophysiology and diagnosis
    • Pathology: Systemic Health — B. Inflammation and repair; 1. Vascular and cellular changes in acute inflammation; 2. Causes of histological changes in chronic inflammation; 3. Causes and features of granulomatous inflammation; 4. Resolution of acute and chronic inflammation; 5. Events and local factors affecting wound healing and repair; 6. Systemic factors affecting the rate of wound healing
    • Pathology: Systemic Health — C. Immunologic system; 1. Epidemiology; 2. Symptoms and signs of immunologic conditions; a. Hypersensitivity disorders (Type I, II, III, IV); b. Autoimmune diseases (e.g., systemic lupus erythematosus, sarcoidosis, reactive arthritis); c. Immunodeficiency diseases (e.g., AIDS); 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — D. Host defenses and responses to infection; 1. PMN, macrophage and eosinophil function; 2. Chemotaxis, phagocytosis, and bacterial activity of these cells; 3. Role of antibody in phagocytosis and destruction of microorganisms
    • Pathology: Systemic Health — E. Cellular disease; 1. Cell injury (reversible and irreversible); 2. Morphological and functional changes associated with cell aging, injury, or death (by necrosis or apoptosis); 3. Cell cycle
    • Pathology: Systemic Health — F. Musculoskeletal system; 1. Epidemiology; 2. Symptoms and signs of the various arthritic syndromes (e.g., JRA, RA, ankylosing spondylitis); 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — G. Integumentary system; 1. Epidemiology; 2. Skin manifestation of systemic disorders; 3. Skin lesions in the phakomatoses; 4. Common dermatoses, including allergic manifestations; 5. Benign, premalignant, and malignant skin lesions; 6. Diagnostic testing and imaging; 7. Pathophysiology and diagnosis
    • Pathology: Systemic Health — H. Head and neck; 1. Epidemiology; 2. Symptoms and signs of diseases of the nasopharynx, sinuses, salivary glands, lymph nodes, carotid and temporal arteries, skin, and temporomandibular joint; 3. Auscultation of carotid arteries, skull and orbits for bruits and venous hum; 4. Potential significance of dysarthria, dysphagia, dysphonia, and hoarseness; 5. Diagnostic testing and imaging; 6. Pathophysiology and diagnosis
    • Pathology: Systemic Health — I. Genetic principles and disorders; 1. Chromosomal disorders (e.g., Down Syndrome); 2. Monogenic disorders; a. Autosomal dominant; b. Autosomal recessive; c. X-linked; 3. Multifactor disorders; 4. Mitochondrial disorders
    • Pathology: Systemic Health — J. Neoplasia; 1. Histogenesis of neoplasms; 2. Classification of neoplasms; 3. Causes of neoplasms; 4. Differences between benign and malignant tumors; 5. Effects of tumor on host, oncogenes, agents; 6. Genetics of neoplasia
    • Pathology: Systemic Health — K. Hematopoietic and lymphoid system; 1. Epidemiology; 2. Symptoms and signs of common blood disorders; a. Non-neoplastic disorders of blood cells; b. Neoplastic disorders of blood cells; c. Non-neoplastic disorders of lymph nodes; d. Neoplastic disorders of lymph nodes; 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — L. Respiratory system; 1. Epidemiology; 2. Symptoms and signs of respiratory disorders; a. Chronic obstructive pulmonary disease (COPD), emphysema, asthma, etc.; b. Infectious diseases of the lung; c. Neoplastic diseases of the lung; d. Interstitial diseases, including pneumoconiosis; 3. Significance of common respiratory symptoms (e.g., cough, hemoptysis, wheezing, shortness of breath); 4. Symptoms and signs of anaphylaxis; 5. Diagnostic testing and imaging; 6. Pathophysiology and diagnosis
    • Pathology: Systemic Health — M. Gastrointestinal system; 1. Epidemiology; 2. Symptoms and signs of common gastrointestinal disorders; a. Diseases of the esophagus (e.g., reflux, motility, disorders); b. Disorders of the stomach (e.g., gastritis, ulcers); c. Disorders of the intestines and colon (e.g., enteritis, colitis); d. Neoplastic disorders of the gastrointestinal tract; e. Diseases of the liver, biliary tract, and pancreas; 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — N. Cardiovascular system; 1. Epidemiology; 2. Risk factors for atherosclerotic heart disease; 3. Symptoms and signs of cardiovascular disease; a. Congestion, edema; b. Hemorrhage, shock; c. Thromboembolism; d. Systemic hypertension; e. Atherosclerosis; f. Aneurysms; g. Vasculitis; h. Coronary artery disease; i. Hypertensive heart disease; j. Bacterial infections and their nonsuppurative sequelae (e.g., rheumatic fever, glomerulonephritis, infective endocarditis); k. Cardiomyopathies; l. Congestive heart failure; 4. Diagnostic testing and imaging; 5. Pathophysiology and diagnosis
    • Pathology: Systemic Health — O. Endocrine/Metabolic system; 1. Epidemiology; 2. Symptoms and signs of endocrine disorders; a. Diabetes; b. Hyperthyroidism (e.g., Graves disease); c. Hypothyroidism; d. Goiters; e. Hyperparathyroidism; f. Hypoparathyroidism; g. Hyperpituitarism; h. Hypopituitarism; i. Hypercortisolism (e.g., Cushing disease); j. Hypocortisolism (e.g., Addison disease); k. Disorders of adrenal medulla (e.g., pheochromocytoma); 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — P. Nervous system and neuromuscular diseases; 1. Epidemiology; 2. Symptoms and signs associated with non-ocular neurological conditions; a. Cerebrovascular diseases; b. Headaches; c. Infectious diseases of the central nervous system; d. Nervous system neoplasms; e. Muscular atrophy, muscular dystrophy; f. Demyelinating diseases; g. Leukodystrophies, gangliosidoses; h. Neurodegenerative diseases (e.g., Alzheimer disease, Parkinson disease); i. Trauma, closed head injuries; j. Autoimmune disorders (e.g., myasthenia gravis); 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — Q. Renal and urogenital system; 1. Epidemiology; 2. Symptoms and signs of urogenital and renal disorders; a. Acute renal failure; b. Chronic renal failure; c. Glomerulonephritis; d. Pyelonephritis; e. Nephrotic syndrome; f. Diabetic nephropathy; g. Neoplasms of the urinary tract; h. Sexually transmitted diseases; i. Cystitis; 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — R. Reproductive system; 1. Epidemiology; 2. Pregnancy; a. Normal physiological changes; b. Pathological changes; 3. Complications of pregnancy (e.g., pre-eclampsia, eclampsia); 4. Implication of breast feeding; 5. Diagnostic testing and imaging; 6. Diseases/disorders; a. Neoplasms (including breast cancer); b. Disorders of the menstrual cycle; c. Disorders of the prostate; d. Erectile dysfunction
    • Pathology: Systemic Health — S. Nutrition; 1. Epidemiology; 2. Symptoms and signs of nutritional abnormalities; a. Malabsorption; b. Alcoholism; c. Vitamin deficiencies and toxicities; d. Trace minerals; e. Eating disorders; 3. Diagnostic testing and imaging; 4. Pathophysiology and diagnosis
    • Pathology: Systemic Health — T. Liver and biliary tract; 1. Epidemiology; 2. Symptoms and signs of liver disorders (e.g., cirrhosis, hepatitis, liver failure); 3. Biliary tract disorders; 4. Diagnostic testing and imaging; 5. Pathophysiology and diagnosis
    • Pathology: Systemic Health — U. Mental illness and behavioral disorders; 1. Epidemiology; 2. Symptoms and signs of mental illness (e.g., depression, suicide, anxiety, schizophrenia, bipolar disorder); 3. Symptoms and signs of behavioral disorders (e.g., substance abuse; child, spouse, and elder abuse); 4. Psychological tests; 5. Pathophysiology and diagnosis
    • Pathology: Systemic Health — V. Congenital/Hereditary conditions; 1. Epidemiology; 2. Symptoms and signs of common genetic disorders (e.g., Down syndrome, cystic fibrosis, congenital anomalies); 3. Symptoms and signs of common congenital disorders (e.g., fetal alcohol syndrome, rubella, syphilis, toxoplasmosis); 4. Diagnostic testing and imaging; 5. Pathophysiology and diagnosis
    • Pathology: Systemic Health — W. Anomalies of child development; 1. Clinical characteristics of children who deviate from expected patterns of development and epidemiology of developmental disorders
    • Pathology: Systemic Health — X. Anomalies of the aging adult; 1. Clinical characteristics of changes in perceptual functions (non-visual) associated with aging; a. Hearing; b. Coordination; c. Cognition; d. Psycho-social status
  • OPTICS (Geometrical, Physical, Ophthalmic, Physiological) — 31% - 35% of scored items (108 - 122 items)
    • Optics (Geometrical): Ametropia — A. Refraction at single spherical or plane surfaces; 1. Curvature and sagitta; 2. Refractive index and rectilinear propagation; 3. Vergence and dioptric power; 4. Object-image relationships, including apparent depth; 5. Ray tracing, nodal point, and nodal ray; 6. Lateral (translinear) and angular magnification; 7. Snell’s law of refraction
    • Optics (Geometrical): Ametropia — B. Thin lenses; 1. Vergence: dioptric and effective power; 2. Object-image relationships; 3. Lateral (translinear) and angular magnification; 4. Thin lens systems; 5. Prismatic effect (Prentice’s rule and prism effectivity); 6. Ray tracing, optical center, and optic axis
    • Optics (Geometrical): Ametropia — C. Thick lenses; 1. Cardinal points; 2. Vertex power and equivalent power; 3. Lateral (translinear) and angular magnification; 4. Reduced systems
    • Optics (Geometrical): Ametropia — D. Aberrations; 1. Spherical; 2. Coma; 3. Oblique astigmatism; 4. Curvature of field; 5. Distortion; 6. Chromatic (longitudinal and lateral)
    • Optics (Geometrical): Ametropia — E. Stops, pupils, and ports; 1. Entrance and exit pupils (size and location); 2. Depth of focus, depth of field, hyperfocal distance; 3. Field of view and half illumination
    • Optics (Geometrical): Ametropia — F. Spherocylindrical lenses; 1. Location of foci, image planes, principal meridians, and circle of least confusion; 2. Obliquely crossed spherocylindrical lenses; 3. Transposition; 4. Prismatic effect
    • Optics (Geometrical): Ametropia — G. Thin prisms; 1. Unit of measurement (prism diopter); 2. Prism deviation; 3. Combination of thin prisms; 4. Resolution of oblique prisms into horizontal and vertical components; 5. Total internal reflection
    • Optics (Geometrical): Ametropia — H. Ophthalmic and optical instruments
    • Optics (Geometrical): Ophthalmic Optics / Spectacles — A. Ophthalmic and optical instruments
    • Optics (Geometrical): Contact Lenses — A. Ophthalmic and optical instruments
    • Optics (Physical): Ametropia — A. Wave optics; 1. Characteristics of wave motion; 2. Classifications of the electromagnetic spectrum; 3. Total and partial coherence; 4. Diffraction (single slit, circular aperture, limits of resolution, zone plates); 5. Interference (double slit, multiple slits, thin film, anti-reflective coatings, holography); 6. Scattering (Rayleigh vs. Tyndall); 7. Dispersion
    • Optics (Physical): Ametropia — B. Interaction of light and matter; 1. Atomic energy levels, absorption, and emission line spectra; 2. Continuous spectra (black body radiator and gray body radiator characteristics); 3. Fluorescence (photons, energy levels); 4. Lasers (theory of operation, speckle pattern); 5. Spectral transmission
    • Optics (Physical): Ophthalmic Optics / Spectacles — A. Polarization; 1. Linearly polarized light; 2. Circular and elliptical polarization; 3. Polarization by reflection (glare reduction, Brewster’s law); 4. Effects of scattering on polarization; 5. Transmission through successive polarizers (stress analysis, Malus’ law)
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — A. Physical characteristics of ophthalmic lenses; 1. Geometry of lens surfaces (spherical, cylindrical, toric, aspheric); 2. Base curves (form of lenses); 3. Lens thickness (center, edge, gradients, iso-thickness curves); 4. Specification of lens size and shape; 5. Materials (refractive index, dispersion, hardness, specific gravity)
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — B. Reflection; 1. Planar and spherical reflection; 2. Proportion of light reflected from a surface (Fresnel’s law); 3. Focal power, focal length, and curvature; 4. Object-image relationships; 5. Magnification; 6. Lens/mirrors systems; 7. Ray tracing
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — C. Optical characteristics of ophthalmic lenses; 1. Locations of the relationships between the optic axis, optical center, geometric center, and major reference points; 2. Principles of corrected curve lens design; 3. Verification of lens prescriptions (lensometer, lens gauge, and hand neutralization); 4. Writing and transposing lens prescriptions; 5. Effect of lens tilt (spheres and spherocylinders about a principal meridian); 6. Effective power (for near and for changes in vertex distances); 7. Spectacle lens processing; 8. Spectacle magnification; a. Shape and power factors; b. Iseikonic lens design; 9. Methods of remedying reflections and ghost images
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — D. Ophthalmic prisms and prismatic effects of lenses; 1. Thickness difference across a prism; 2. Prismatic effects in the periphery of a lens (spheres, spherocylinders); 3. Decentration (prism from decentration, decentering to obtain prism, interpupillary distance); 4. Correction of vertical prism effect:; a. Slab off (front, back, top, bottom, reverse); b. Dissimilar segments; c. Prism segments; d. Multiple corrections; e. Contact lenses; f. Fresnel prisms; g. Fresnel Adds
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — E. Multifocal lenses; 1. Types (fused, 1-piece, progressive additions, and blended lenses); 2. Methods of producing Add powers; 3. Segment center location; 4. Differential displacement (jump); 5. Total displacement, horizontal and vertical imbalance; 6. Placement of distance and multifocal optical center; 7. Optical and physical characteristics of segments (design and calculations, progressive Adds, aberrations, surface characteristics); 8. Specifying multifocal height, size, shape, and location of segment
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — F. Physical characteristics and biological compatibility of frame materials
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — G. Fittings, adjustment, specification, and nomenclature of frames
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — H. Optical and frame consideration of high-powered lenses: aspheric, aspheric, and high refractive index materials
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — I. Absorptive lenses; 1. Specification of lens tints and absorptive coatings (including spectral transmission curves); 2. Characteristics of photochromic lenses; 3. Relationship between lens thickness and spectral transmission; 4. Special occupational requirements
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — J. Impact resistance; 1. Degrees of resistance of ophthalmic lens materials; 2. Methods of rendering materials impact resistant; 3. Methods of verifying impact resistance; 4. Performance of materials upon, and after, impact; 5. Specifications of occupational safety lenses
    • Optics (Ophthalmic): Ophthalmic Optics / Spectacles — K. Optical tolerances and physical requirements of ophthalmic lenses and frame materials (FDA, ANSI Z80 and Z87, OSHA)
    • Optics (Ophthalmic): Contact Lenses — A. Optical characteristics of contact lenses; 1. Surface characteristics of the lens and the cornea; 2. Specification of the lens (power, base curve, thickness, and edge characteristics); 3. Effective power considerations of the contact lenses; 4. Tear-lens optical considerations; 5. Prismatic effects; 6. Fabrication, inspection, and verification; 7. Lens types and materials; 8. Optical filters (photochromic lenses); 9. Optics of contact lenses: curves, zones, widths, and tear lens effects; sagittal depth; center edge thickness; flexure; asphericity and toric designs
    • Optics (Ophthalmic and Physiological): Low Vision — A. Epidemiology; 1. Causes of visual impairment; 2. Classification
    • Optics (Ophthalmic and Physiological): Low Vision — B. Examination and testing; 1. Visual acuity; 2. Special refraction techniques; 3. Visual fields; 4. Reading skills; 5. Effects of illumination; 6. Magnification determination; 7. In-office evaluation with low vision devices
    • Optics (Ophthalmic and Physiological): Low Vision — C. Management and rehabilitation; 1. Optical management:; a. Magnification, field of view, and working distance; b. Simple magnifiers; c. Telescopes; d. Loupes; e. Microscopes; 2. Electronic (digital) management:; a. Magnification, field of view, and working distance; 3. Orientation and mobility
    • Optics (Physiological): Ametropia — A. Refractive states: emmetropia, myopia, hyperopia, astigmatism, presbyopia, anisometropia; 1. Epidemiology, history, and symptoms inventory; 2. Observation and recognition of clinical signs, and techniques and skills including determination of:; a. Interpupillary distance; b. Visual acuity; c. Corneal curvature and thickness; d. Objective static and dynamic refractive status, including automatic refractive devices; e. Standard subjective refraction procedures, including astigmatic dials, crossed cylinders, stenopaic slit, fogging methods, bichrome and accommodation balance (equalization) techniques; f. Binocular subjective refraction procedures, including Turville infinity balance and vectographic (Polaroid) techniques; g. Cycloplegic subjective and objective techniques; h. Amplitude of accommodation; i. Trial lenses; j. PRA/NRA; k. Add powers; l. Refractive correction applications (e.g., LASIK); 3. Management of refractive states:; a. Optical; b. Surgical; c. Pharmacological; d. Myopia control
    • Optics (Physiological): Ametropia — B. Anomalies of refraction: aphakia, pseudophakia, and aniseikonia; 1. Epidemiology, history, and symptom inventory; 2. Observation and recognition of clinical signs and phenomena associated with aphakia and pseudophakia:; a. Magnification; b. Field of view; c. Spatial distortion; d. Convergence demands; e. Sensitivity to glare; f. Techniques and skills for determining, evaluating, and/or verifying:; i. Types and characteristics of intraocular lenses and aphakic spectacle and contact lenses; ii. Intraocular lens power; iii. Special refraction techniques; iv. Aphakic lens prescriptions; 3. Observation and recognition of clinical signs, and techniques and skills associated with aniseikonia including:; a. Detection of aniseikonia; b. Measurement of aniseikonia
    • Optics (Physiological): Ametropia — C. Schematic eye models; 1. Dioptric components; 2. Cardinal points, entrance and exit pupils; 3. Ametropia: far point, near point, correction; 4. Accommodation: amplitude and effectivity; 5. Astigmatism, including correction; 6. Retinal image size, spectacle magnification, and relative spectacle magnification
    • Optics (Physiological): Ametropia — D. Dioptrics of the eye; 1. Characteristics of components (curvature, thickness, separation, refractive indices, and axil length); 2. Reference angles and axes; 3. Catoptric (Purkinje) images; 4. Retinal image size; 5. Optical function of the pupil
    • Optics (Physiological): Ametropia — E. Image quality; 1. Aberrations (surgically induced, spherical, chromatic, coma, curvature, oblique astigmatism, distortion, wavefront sensing aberrometry); 2. Diffraction; 3. Stray light; 4. Point and line spread functions; 5. Resolving power; 6. Modulation transfer function (Fourier optics)
    • Optics (Physiological): Ametropia — F. Radiation and the eye; 1. Radiometry (radiant intensity, radiance, and irradiance); 2. Photometry (luminosity function, luminous intensity, luminance, and illuminance, Lambertian surfaces- cosine laws); 3. Spectral transmission of the ocular media; 4. Retinal illuminance; 5. Effects of incoherent radiation (e.g., infrared, visible, ultraviolet) on tissue:; a. Mechanisms of damage; b. Wavelength, energy levels, thresholds for reactions; c. Ophthalmic applications (e.g., intense pulsed light therapy (IPL), corneal cross-linking); d. Protective measures; 6. Effects of coherent radiation (lasers) on tissue:; a. Mechanisms of damage; b. Wavelength, energy levels, thresholds for reactions; c. Ophthalmic applications (argon, excimer, YAG, SLT, helium neon, holmium); d. Protective measures
    • Optics (Physiological): Contact Lenses — A. Basic theories and methods of fitting, and contact lens selection and designs
    • Optics (Physiological): Contact Lenses — B. Patient selection and post-fitting complications
    • Optics (Physiological): Accommodation / Vergence / Oculomotor Function — A. Eye movements; 1. Purpose of roles for vision; 2. Dynamics and kinematics; 3. Specification of direction of gaze and ocular orientation (torsion); 4. Reflex movements, including compensatory movements (e.g., vestibulo-ocular reflex, optokinetic nystagmus); 5. Small movements associated with steady fixation; 6. Versional movements (pursuits and saccades); 7. Vergence movements (tonic, accommodative, including models of accommodative/vergence interaction, fusional and proximal)
    • Optics (Physiological): Accommodation / Vergence / Oculomotor Function — B. Anomalies and eye movements; 1. Epidemiology, history, and symptom inventory; 2. Observation and recognition of clinical signs, and techniques and skills to test:; a. Comitance; b. Deviations and measurements thereof; c. Diplopia; d. Motor fusion; e. Paralytic syndromes; f. Fixation disparity; g. Nystagmus
    • Optics (Physiological): Accommodation / Vergence / Oculomotor Function — C. Accommodation and accommodative vergence; 1. Epidemiology, history, and symptom inventory; 2. Observation and recognition of clinical signs, and techniques and skills to test:; a. Amplitude range, facility of accommodation; b. Analysis of accommodation and vergence relationships; c. Vision therapy procedures, demands, and challenges; 3. Biomechanics of accommodative reflexes
    • Optics (Physiological): Accommodation / Vergence / Oculomotor Function — D. Pupils; 1. Purposes and roles for vision; 2. Dynamics of muscle action; 3. Biomechanics of pupillary reflexes; 4. Interrelationships between pupillary changes, accommodation, and convergence (the near reflex); 5. Factors affecting pupil size
    • Optics (Physiological): Amblyopia / Strabismus — A. Sensory anomalies of binocular vision/strabismus; 1. Epidemiology, history, and symptom inventory; 2. Observation and recognition of clinical signs, and techniques and skills to test:; a. Monocular fixation patterns; b. Amblyopia; c. Sensory fusion and stereopsis; d. Anomalous correspondence; e. Suppression
    • Optics (Physiological): Perceptual Function / Color Vision — A. Anomalies secondary to acquired neurological impairment; 1. Adaptations to clinical techniques and tests to allow the assessment of visual abilities of patients with acquired systemic conditions (CVA, multiple sclerosis, etc.) and traumatic brain injury (TBI), which results in neurological impairment and subsequent vision perceptual dysfunction:; a. Noncomitancy; b. Field loss and neglect; c. Loss of accommodation; d. Loss of fusion; e. Vision perception-motor deficiencies; 2. Modification of optometric management for the patient with acquired neurological impairment
    • Optics (Physiological): Perceptual Function / Color Vision — B. Space perception; 1. Direction and depth discrimination (monocular and binocular cues, oculocentric and egocentric localization); 2. Characteristics of sensory function (binocular interactions including summation, binocular suppression, and rivalry; corresponding points including horopter criteria); 3. Disturbances of perceived direction and distance (aniseikonia and amblyopia); 4. Sensory-motor interactions (fixation disparity, past pointing, visually guided behavior, body posture and perceived orientation, and self-motion)
    • Optics (Physiological): Perceptual Function / Color Vision — C. Form perception; 1. Static visual acuity (including test configurations, various acuity tasks, and factors influencing acuity including blur, intensity, and contrast); specification of visual acuity; 2. Spatial contrast sensitivity function (including factors influencing the function); 3. Illusions, constancies, and figure-ground relations; 4. Simultaneous contrast and spatial interactions (Mach bands)
    • Optics (Physiological): Perceptual Function / Color Vision — D. Light perception; 1. Detection characteristics at the absolute light threshold (including spectral, spatial, and temporal aspects); 2. Brightness difference thresholds at various adaptation levels (Weber’s and DeVries-Rose laws); specification of contrast; 3. Dark and light adaptation processes and theories; 4. Spatial and temporal summation characteristics (Ricco’s, Piper’s, and Bloch’s laws)
    • Optics (Physiological): Perceptual Function / Color Vision — E. Motion perception; 1. Factors involved in the detection of real and apparent motion, detection of displacements; 2. Motion after-effects; 3. Dynamic visual acuity, visual performances with a moving object, and visual performances with a moving observer
    • Optics (Physiological): Perceptual Function / Color Vision — F. Temporal perception; 1. Critical flicker fusion frequency, including factor influencing test object (size, location, and adaptation level); 2. Subfusional flicker phenomena (Bartley brightness enhancement); 3. Successive contrast and masking; 4. Temporal contrast sensitivity function; 5. Stabilized retinal images and monocular suppression (Troxler effect); 6. Saccadic suppression
    • Optics (Physiological): Perceptual Function / Color Vision — G. Entopic phenomena; 1. Characteristics and origin of various phenomena (involving the cornea, lens, and vitreous); 2. Vascular and circulatory phenomena (Purkinje tree, capillary circulation); 3. Phenomena associated with central vision (Maxwell spot, Haidinger brushes); 4. Phenomena associated with retinal distention or other forms of retinal activity (Moore lightning streaks, blue arcs of the retina, phosphenes)
    • Optics (Physiological): Perceptual Function / Color Vision — H. Color perception; 1. Chromatic discrimination (hue and saturation) for normal and defective color vision; 2. Color mixture and appearance; 3. Color contrast, constancy, and adaptation; 4. Color specification and colorimetry (CIE); 5. Spectral sensitivity of normal and defective color vision; 6. Mechanisms of color deficiencies; 7. Inherited anomalies of color vision:; a. Classification; b. Inheritance patterns; c. Color vision tests (e.g., pseudoisochromatic tests, arrangement tests, anomaloscope); 8. Acquired anomalies of color vision:; a. Classification; b. Etiology; c. Color vision tests; 9. Conditions for color vision testing; 10. Societal implication of color vision anomalies:; a. School; b. Vocational requirements; c. Patient interest; 11. Patient management strategies:; a. Counseling; b. Special aids
    • Optics (Physiological): Perceptual Function / Color Vision — I. Basic psychophysical methods and theory; 1. Measurement of absolute and difference thresholds; 2. Threshold determination (e.g., limits, adjustments, constant stimuli, forced choice, yes/no)
    • Optics (Physiological): Perceptual Function / Color Vision — J. Psychophysical scaling methods and theory
    • Optics (Physiological): Perceptual Function / Color Vision — K. Signal detection methods and theory
    • Optics (Physiological): Visual and Human Development — A. Vision development in the infant child; 1. Spatial vision; 2. Refractive error; 3. Color vision; 4. Spectral transmission of the ocular media; 5. Accommodation and convergence; 6. Light sensitivity; 7. Binocular vision and stereopsis; 8. Form reproduction and perception; 9. Temporal vision; 10. Visual fields; 11. Motion perception
    • Optics (Physiological): Visual and Human Development — B. Effects of early environmental restrictions; 1. Plasticity of the system; 2. Animal models; 3. Light and pattern deprivation; 4. Monocular and binocular deprivation; 5. Refractive error; 6. Strabismus; 7. Cataract
    • Optics (Physiological): Visual and Human Development — C. Changes in vision with aging; 1. Spatial vision; 2. Refractive error; 3. Color vision; 4. Spectral transmission of the ocular media; 5. Accommodation and convergence; 6. Light sensitivity; 7. Glare (disability and discomfort); 8. Dark adaptation, glare recovery; 9. Visual fields; 10. Temporal vision; 11. Oculomotor system; 12. Motion perception; 13. Visual attention
    • Optics (Physiological): Visual and Human Development — D. Vision perceptual-motor skills
    • Optics (Physiological): Visual and Human Development — E. Anomalies of child development; 1. Epidemiology: history and signs/symptoms manifest by patients in the age ranges noted below in (2); 2. Clinical techniques and tests to assess the development of an infant (birth to 18 months), toddler (18-36 months), preschooler (3-5 years), and school-age child; 3. Vision problems which may be associated with deviations from normal patterns of development; 4. Tests used by optometrists to determine a child’s level of visual-perceptual development, such as:; a. Visual attention and discrimination; b. Visual-motor integration; c. Intersensory integration; d. Bilateral integration and laterality
  • PHARMACOLOGY — 11% - 17% of scored items (40 - 60 items)
    • Pharmacology: Contact Lenses — A. Preparation used with contact lenses; 1. Preserved and non-preserved solutions; 2. Drug delivery systems
    • Pharmacology: Contact Lenses — B. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Accommodation / Vergence / Oculomotor Function — A. Autonomic and/or neuromuscular junction drugs; 1. Drugs affecting neurohumoral transmission: autonomic and somatic motor nervous systems; 2. Adrenergic agonists; 3. Adrenergic antagonists; 4. Cholinergic agonists; 5. Cholinergic antagonists; 6. Cholinesterase inhibitors; 7. Ganglionic agonists and antagonists; 8. Neuromuscular transmission agonists and antagonists
    • Pharmacology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — B. Anti-infective agents
    • Pharmacology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — C. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — D. Aesthetic/cosmetic agents
    • Pharmacology: Lids / Lashes / Lacrimal System / Ocular Adnexa / Orbit — E. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — B. Ocular anesthetics
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — C. Antihistamines
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — D. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — E. Lubricants and tear substitutes
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — F. Dyes; 1. Topical diagnostic agents
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — G. Hyperosmotic agents
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — H. Mast cell stabilizers
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — I. Vasoconstrictors
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — J. Immune modulators
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — K. Anti-infective agents
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — L. Nutritional supplements
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — M. Biologics
    • Pharmacology: Conjunctiva / Cornea / Refractive Surgery — N. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Lens / Cataract / IOL / Pre- and Post-Operative Care — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Lens / Cataract / IOL / Pre- and Post-Operative Care — B. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Lens / Cataract / IOL / Pre- and Post-Operative Care — C. Anti-infective agents
    • Pharmacology: Lens / Cataract / IOL / Pre- and Post-Operative Care — D. Lubricants and tear substitutes
    • Pharmacology: Lens / Cataract / IOL / Pre- and Post-Operative Care — E. Dyes; 1. Topical diagnostic agents; 2. Intraoperative agents
    • Pharmacology: Lens / Cataract / IOL / Pre- and Post-Operative Care — F. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Episclera / Sclera / Anterior Uvea — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Episclera / Sclera / Anterior Uvea — B. Mydriatics and cycloplegics
    • Pharmacology: Episclera / Sclera / Anterior Uvea — C. Miotics
    • Pharmacology: Episclera / Sclera / Anterior Uvea — D. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Episclera / Sclera / Anterior Uvea — E. Lubricants and tear substitutes
    • Pharmacology: Episclera / Sclera / Anterior Uvea — F. Dyes; 1. Topical diagnostic agents; 2. Intravenous agents
    • Pharmacology: Episclera / Sclera / Anterior Uvea — G. Vasoconstrictors
    • Pharmacology: Episclera / Sclera / Anterior Uvea — H. Indications/contraindications/side effects/ drug interactions
    • Pharmacology: Vitreous / Retina / Choroid — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Vitreous / Retina / Choroid — B. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Vitreous / Retina / Choroid — C. Anti-infective agents
    • Pharmacology: Vitreous / Retina / Choroid — D. Dyes; 1. Topical diagnostic agents; 2. Intravenous agents
    • Pharmacology: Vitreous / Retina / Choroid — E. Nutritional supplements
    • Pharmacology: Vitreous / Retina / Choroid — F. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Optic Nerve / Neuro-Ophthalmic Pathways — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Optic Nerve / Neuro-Ophthalmic Pathways — B. Mydriatics and cycloplegics
    • Pharmacology: Optic Nerve / Neuro-Ophthalmic Pathways — C. Miotics
    • Pharmacology: Optic Nerve / Neuro-Ophthalmic Pathways — D. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Optic Nerve / Neuro-Ophthalmic Pathways — E. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Glaucoma — A. General principles; 1. Factors affecting drug bioavailability; 2. Routes of administration; 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Glaucoma — B. Antiglaucoma agents
    • Pharmacology: Glaucoma — C. Hyperosmotic agents
    • Pharmacology: Glaucoma — D. Mydriatics and cycloplegics
    • Pharmacology: Glaucoma — E. Indications/contraindications/side effects/drug interactions
    • Pharmacology: Systemic Health — A. General principles; 1. Pharmacodynamics; a. Concept of receptors; b. Dose-response relationships; c. Routes of drug administration; 2. Pharmacokinetics; a. Absorption, distribution, metabolism, and excretion of drugs; b. Quantitative aspects; c. Influencing factors (e.g., age, gender, pathology, genetics, diet); 3. Mechanisms of action; 4. Preservatives
    • Pharmacology: Systemic Health — B. Autonomic and/or neuromuscular junction drugs; 1. Drugs affecting neurohumoral transmission: autonomic and somatic motor nervous systems; 2. Adrenergic agonists; 3. Adrenergic antagonists; 4. Cholinergic agonists; 5. Cholinergic antagonists; 6. Cholinesterase inhibitors; 7. Ganglionic agonists and antagonists; 8. Neuromuscular transmission agonists and antagonists
    • Pharmacology: Systemic Health — C. Autacoid agonists and antagonists
    • Pharmacology: Systemic Health — D. Drugs affecting the respiratory system; 1. Bronchodilators; 2. Mast cell stabilizers; 3. Mucolytics
    • Pharmacology: Systemic Health — E. Gastrointestinal agents
    • Pharmacology: Systemic Health — F. Chemotherapeutics agents; 1. Antimicrobial agents; a. Antiseptics and disinfectants; b. Antibacterial; c. Antifungal; d. Antiparasitic; 2. Antiviral agents; 3. Antineoplastic agents
    • Pharmacology: Systemic Health — G. Immunopharmacological agents
    • Pharmacology: Systemic Health — H. Anti-inflammatory agents; 1. Steroids; 2. Non-steroidals
    • Pharmacology: Systemic Health — I. Major drugs acting on the central nervous system; 1. Neurotransmitters; 2. Opioid and non-opioid analgesics; 3. Sedative hypnotics; 4. Anxiolytics; 5. Antipsychotics; 6. Antiparkinsonians; 7. Antidepressants; 8. Anticonvulsants; 9. Skeletal muscle relaxants; 10. Hallucinogens and drugs of abuse
    • Pharmacology: Systemic Health — J. General and local anesthetics
    • Pharmacology: Systemic Health — K. Major drugs acting on the endocrine system; 1. Adenohypophyseal hormones; 2. Thyroid and antithyroid drugs; 3. Insulin and synthetic antidiabetics; 4. Estrogens, progestins and androgens
    • Pharmacology: Systemic Health — L. Major cardiovascular drugs; 1. Antihypertensives; 2. Agents used to treat CHF (e.g., inotropic agents, vasodilators); 3. Antiarrhythmics; 4. Antianginal agents; 5. Anticoagulants and thrombolytics; 6. Antihyperlipidemic agents
    • Pharmacology: Systemic Health — M. Major drugs acting on the kidneys; 1. Diuretics; 2. Uricosuric agents
    • Pharmacology: Systemic Health — N. Nutritional supplements
    • Pharmacology: Systemic Health — O. Indications/contradictions/side effects/drug interactions
    • Pharmacology: Systemic Health — P. Drug use and metabolism in pregnancy and breast feeding
Examination sources

Part II Patient Assessment and Management (PAM)

Provider
National Board of Examiners in Optometry (NBEO); delivered at Pearson Testing Centers
Format
One-day computer-based, image-intensive, case-based examination; each patient case is followed by 3-6 related multiple-choice items with 3-10 answer options; items may be single-answer or multiple-response (up to 4 correct answers, all required for credit). Includes approximately 120 embedded TMOD items, reported as a separate TMOD breakout score and pass/fail decision
Exam questions
350 items
Time limit
Two sessions of 175 items each, 3.5 hours per session
Passing score
Scaled score on a 100-900 scale; anything above 300 is a passing score
Exam fee
$1490 (rates for examinations administered beginning August 2026)
Examination outline
  • Clinical Correlation of Basic Science Principles — 11% - 17% of items (40 - 60 items); includes embedded Treatment and Management of Ocular Disease (TMOD) items
    • Clinical Correlation of Basic Science Principles — Pathophysiology/etiology
    • Clinical Correlation of Basic Science Principles — anatomy
    • Clinical Correlation of Basic Science Principles — biochemistry
    • Clinical Correlation of Basic Science Principles — physiology
    • Clinical Correlation of Basic Science Principles — immunology/microbiology/pathology
    • Clinical Correlation of Basic Science Principles — optics
    • Clinical Correlation of Basic Science Principles — pharmacology
  • Diagnosis — 26% - 34% of items (90 - 120 items); includes embedded Treatment and Management of Ocular Disease (TMOD) items
    • Diagnosis — Most appropriate diagnosis
    • Related to Diagnosis — Indicate data supporting or correlating with diagnosis; correlation of possible additional data; or indicate additional data or next test needed
  • Treatment / Management — 40% - 57% of items (140 - 200 items); includes embedded Treatment and Management of Ocular Disease (TMOD) items
    • Treatment/Management — Most appropriate treatment/management
    • Related to Treatment/Management — Treatment mechanism, additional data needed to treat effectively, additional data or next test needed, patient education, follow-up, or prognosis
  • Legal Issues / Ethics / Public Health — 4% - 10% of items (15 - 35 items)
    • Legal Issues / Ethics — Licensure and governmental regulation of optometry, standards of professional ethics, doctor-patient relationship, professional liability
    • Public Health — Epidemiology, biostatistics and measurement, environmental vision, health care policy and administration
Examination sources

Part III Patient Encounters and Performance Skills (PEPS)

This assessment does not have a question bank.

Provider
National Board of Examiners in Optometry (NBEO); administered at the National Center of Clinical Testing in Optometry (NCCTO), Charlotte, NC
Format
12-station performance-based examination with standardized patients: 10 patient encounter stations and 2 performance skills stations; every station cycle is audio and video recorded; encounter notes and skills are scored by licensed optometrist examiners
Time limit
4.5-hour session; each exam cycle is 15 minutes with 3 minutes of observation time
Passing score
Pass/fail against an overall cut-off requirement; scale scores are not reported
Exam fee
$1490 (rates for examinations administered beginning August 2026)
Examination sources

Nevada Online State Law Exam (OSLE)

Provider
Nevada State Board of Optometry; online administration by NBEO
Format
Remote, open-book; multiple-choice and true/false
Exam questions
100
Time limit
4 hours once logged into exam
Passing score
70%
Examination outline
  • NRS Chapter 636 - Optometry
  • NAC Chapter 636 - Optometry
Examination sources